Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 207

1.

MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation.

Fortuna D, Boman B, O'Neill R, Palazzo J.

Hum Pathol. 2017 May;63:177-183. doi: 10.1016/j.humpath.2017.02.020. Epub 2017 Mar 14.

PMID:
28302537
2.

Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions.

Razavi SM, Jafari M, Heidarpoor M, Khalesi S.

Malays J Pathol. 2015 Dec;37(3):253-8.

3.

Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family.

Gao J, Wang Q, Dong C, Chen S, Qi Y, Liu Y.

PLoS One. 2015 Jul 21;10(7):e0133522. doi: 10.1371/journal.pone.0133522. eCollection 2015.

4.
5.

MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.

Zhang X, Teng Y, Yang F, Wang M, Hong X, Ye LG, Gao YN, Chen GY.

Oncol Rep. 2015 May;33(5):2599-605. doi: 10.3892/or.2015.3822. Epub 2015 Feb 27.

PMID:
25738322
6.

Correlation of MCM2 detection with stage and virology of cervical cancer.

Amaro Filho SM, Nuovo GJ, Cunha CB, Ramos Pereira Lde O, Oliveira-Silva M, Russomano F, Pires A, Nicol AF.

Int J Biol Markers. 2014 Dec 9;29(4):e363-71. doi: 10.5301/jbm.5000081.

PMID:
24706378
7.

MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells.

Liu Y, He G, Wang Y, Guan X, Pang X, Zhang B.

Toxicol Lett. 2013 Jul 31;221(1):23-30. doi: 10.1016/j.toxlet.2013.05.643. Epub 2013 Jun 13.

PMID:
23770000
8.

High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.

Gouvêa AF, Santos Silva AR, Speight PM, Hunter K, Carlos R, Vargas PA, de Almeida OP, Lopes MA.

Histopathology. 2013 Mar;62(4):551-62. doi: 10.1111/his.12036. Epub 2013 Jan 24.

PMID:
23347057
9.

MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.

Liu M, Li JS, Tian DP, Huang B, Rosqvist S, Su M.

Histol Histopathol. 2013 Apr;28(4):481-92. doi: 10.14670/HH-28.481. Epub 2013 Jan 18.

PMID:
23329420
10.

Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases.

Toubaji A, Sutcliffe S, Chaux A, Lecksell K, Hicks J, De Marzo AM, Platz EA, Netto GJ.

Hum Pathol. 2012 Nov;43(11):1852-65. doi: 10.1016/j.humpath.2012.01.007. Epub 2012 May 2.

11.

Overexpression of MCM2 in myelodysplastic syndromes: association with bone marrow cell apoptosis and peripheral cytopenia.

Suzuki S, Kurata M, Abe S, Miyazawa R, Murayama T, Hidaka M, Yamamoto K, Kitagawa M.

Exp Mol Pathol. 2012 Feb;92(1):160-6. doi: 10.1016/j.yexmp.2011.11.003. Epub 2011 Nov 15.

PMID:
22115939
12.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.

PMID:
21947329
13.

Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.

Werynska B, Pula B, Muszczynska-Bernhard B, Piotrowska A, Jethon A, Podhorska-Okolow M, Dziegiel P, Jankowska R.

Anticancer Res. 2011 Sep;31(9):2833-9.

PMID:
21868526
14.

Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.

Taran K, Sitkiewicz A, Andrzejewska E, Kobos J.

Pol J Pathol. 2011;62(2):84-8.

15.

A fraction of MCM 2 proteins remain associated with replication foci during a major part of S phase.

Mašata M, Juda P, Raška O, Cardoso MC, Raška I.

Folia Biol (Praha). 2011;57(1):3-11.

16.

Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China.

Huang B, Hu B, Su M, Tian D, Guo Y, Lian S, Liu Z, Wu X, Li Q, Zheng R, Gao Y.

Hum Pathol. 2011 Jun;42(6):808-16. doi: 10.1016/j.humpath.2010.04.022. Epub 2011 Jan 15.

PMID:
21237484
17.

Minichromosome maintenance protein expression according to the grade of atypism in actinic keratosis.

Shin JW, Kim YK, Cho KH.

Am J Dermatopathol. 2010 Dec;32(8):794-8. doi: 10.1097/DAD.0b013e3181de4e93.

PMID:
20847638
18.

Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adenomas.

Dallago CM, Barbosa-Coutinho LM, Ferreira NP, Meurer R, Pereira-Lima JF, Oliveira Mda C.

Endocr Pathol. 2010 Mar;21(1):32-9. doi: 10.1007/s12022-010-9107-x.

PMID:
20174894
19.

MCM 2 Expression in Basal Cell Carcinomas and Trichoepitheliomas.

Liaw K, Boyd AS.

J Cutan Pathol. 2009 Oct;36(10):1121-2. doi: 10.1111/j.1600-0560.2009.01269.x. Epub 2009 Jun 11. No abstract available.

PMID:
19522849
20.

Supplemental Content

Support Center